Liver-Selective Glucocorticoid Antagonists:  A Novel Treatment for Type 2 Diabetes

MLA

Geldern, T. W.von, et al. “Liver-Selective Glucocorticoid Antagonists:  A Novel Treatment for Type 2 Diabetes.” Journal of Medicinal Chemistry, vol. 47, no. 17, Aug. 2004, pp. 4213–30. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs6303184&authtype=sso&custid=ns315887.

APA

Geldern, T. W. von, Tu, N., Kym, P. R., Link, J. T., Jae, H.-S., Lai, C., Apelqvist, T., Rhonnstad, P., Hagberg, L., Koehler, K., Grynfarb, M., Goos-Nilsson, A., Sandberg, J., Osterlund, M., Barkhem, T., Hoglund, M., Wang, J., Fung, S., Wilcox, D., … Jacobson, P. B. (2004). Liver-Selective Glucocorticoid Antagonists:  A Novel Treatment for Type 2 Diabetes. Journal of Medicinal Chemistry, 47(17), 4213–4230.

Chicago

Geldern, T. W. von, N. Tu, P. R. Kym, J. T. Link, H.-S. Jae, C. Lai, T. Apelqvist, et al. 2004. “Liver-Selective Glucocorticoid Antagonists:  A Novel Treatment for Type 2 Diabetes.” Journal of Medicinal Chemistry 47 (17): 4213–30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs6303184&authtype=sso&custid=ns315887.